Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniopharyngioma | 3 | 2018 | 271 | 1.260 |
Why?
|
| Pituitary Neoplasms | 4 | 2020 | 1234 | 0.990 |
Why?
|
| Ganglioneuroma | 1 | 2018 | 59 | 0.710 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 38 | 0.690 |
Why?
|
| Pinealoma | 1 | 2017 | 56 | 0.690 |
Why?
|
| Neurosurgical Procedures | 6 | 2017 | 1888 | 0.660 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2017 | 87 | 0.660 |
Why?
|
| Pineal Gland | 1 | 2017 | 165 | 0.650 |
Why?
|
| Central Nervous System Cysts | 1 | 2016 | 58 | 0.620 |
Why?
|
| Neurofibromatosis 2 | 1 | 2019 | 350 | 0.620 |
Why?
|
| Teratoma | 1 | 2018 | 379 | 0.600 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 533 | 0.550 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 435 | 0.530 |
Why?
|
| Cilia | 2 | 2016 | 456 | 0.510 |
Why?
|
| Forkhead Transcription Factors | 2 | 2017 | 1551 | 0.500 |
Why?
|
| Stromal Cells | 1 | 2018 | 1385 | 0.480 |
Why?
|
| Homeodomain Proteins | 2 | 2021 | 2531 | 0.440 |
Why?
|
| Trans-Activators | 1 | 2017 | 3150 | 0.320 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 1429 | 0.300 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 4648 | 0.220 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 238 | 0.210 |
Why?
|
| New York | 6 | 2018 | 856 | 0.210 |
Why?
|
| Computer Graphics | 1 | 2021 | 359 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 8610 | 0.200 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 186 | 0.200 |
Why?
|
| Copper | 1 | 2022 | 405 | 0.190 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5354 | 0.190 |
Why?
|
| Adenoma | 2 | 2020 | 2143 | 0.180 |
Why?
|
| Smooth Muscle Tumor | 1 | 2017 | 62 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 1154 | 0.170 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 8590 | 0.170 |
Why?
|
| Azepines | 1 | 2019 | 350 | 0.160 |
Why?
|
| Zebrafish | 3 | 2013 | 2969 | 0.160 |
Why?
|
| Propensity Score | 3 | 2017 | 1751 | 0.150 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 771 | 0.140 |
Why?
|
| Hospital Charges | 1 | 2017 | 364 | 0.140 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 582 | 0.140 |
Why?
|
| Telomere | 1 | 2020 | 797 | 0.140 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2021 | 676 | 0.140 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2013 | 58 | 0.140 |
Why?
|
| Databases, Factual | 4 | 2017 | 7865 | 0.130 |
Why?
|
| Consumer Health Information | 1 | 2016 | 231 | 0.130 |
Why?
|
| Medulloblastoma | 1 | 2019 | 692 | 0.130 |
Why?
|
| Internet | 2 | 2016 | 3097 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 2772 | 0.130 |
Why?
|
| Ovary | 1 | 2018 | 1016 | 0.130 |
Why?
|
| Myocytes, Cardiac | 2 | 2013 | 1589 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2011 | 1130 | 0.130 |
Why?
|
| Triazoles | 1 | 2019 | 931 | 0.120 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2021 | 973 | 0.120 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 1163 | 0.120 |
Why?
|
| Endovascular Procedures | 2 | 2015 | 1791 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2019 | 845 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2018 | 4632 | 0.110 |
Why?
|
| Natriuretic Peptides | 1 | 2011 | 123 | 0.110 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2018 | 803 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2019 | 3066 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2018 | 60991 | 0.100 |
Why?
|
| Registries | 2 | 2017 | 8033 | 0.100 |
Why?
|
| Data Mining | 1 | 2015 | 548 | 0.100 |
Why?
|
| Luciferases | 1 | 2011 | 773 | 0.100 |
Why?
|
| Humans | 27 | 2022 | 686663 | 0.100 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 1068 | 0.100 |
Why?
|
| Organogenesis | 1 | 2011 | 241 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1770 | 0.090 |
Why?
|
| Hospitals | 2 | 2018 | 2930 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2017 | 3092 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2018 | 1713 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2015 | 1031 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 756 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 1464 | 0.080 |
Why?
|
| Brain Ischemia | 2 | 2018 | 3150 | 0.080 |
Why?
|
| Stroke | 2 | 2018 | 8730 | 0.080 |
Why?
|
| Cohort Studies | 6 | 2018 | 38732 | 0.080 |
Why?
|
| Length of Stay | 5 | 2018 | 6241 | 0.080 |
Why?
|
| Intracranial Aneurysm | 1 | 2015 | 1196 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 1544 | 0.070 |
Why?
|
| Middle Aged | 10 | 2020 | 216468 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2011 | 2775 | 0.070 |
Why?
|
| Female | 13 | 2020 | 375459 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 1185 | 0.070 |
Why?
|
| Patient Discharge | 4 | 2017 | 2754 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3396 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 2963 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 12095 | 0.060 |
Why?
|
| Proteins | 1 | 2019 | 6264 | 0.060 |
Why?
|
| Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2022 | 12 | 0.060 |
Why?
|
| Adult | 7 | 2020 | 211400 | 0.060 |
Why?
|
| Ionophores | 1 | 2022 | 99 | 0.060 |
Why?
|
| Genomics | 1 | 2018 | 4921 | 0.060 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2022 | 84 | 0.060 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2022 | 80 | 0.060 |
Why?
|
| Hospital Mortality | 4 | 2017 | 5065 | 0.060 |
Why?
|
| Lipoylation | 1 | 2022 | 64 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 13603 | 0.060 |
Why?
|
| Male | 11 | 2020 | 352465 | 0.060 |
Why?
|
| Cell Respiration | 1 | 2022 | 215 | 0.060 |
Why?
|
| Heart | 2 | 2013 | 4233 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2017 | 4173 | 0.060 |
Why?
|
| Aged | 7 | 2020 | 162271 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 28923 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2021 | 11910 | 0.050 |
Why?
|
| Hydrazines | 1 | 2022 | 220 | 0.050 |
Why?
|
| Pediatrics | 1 | 2016 | 3572 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39737 | 0.050 |
Why?
|
| Cyclin D2 | 1 | 2019 | 103 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11833 | 0.050 |
Why?
|
| Physicians | 1 | 2016 | 4060 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2011 | 3230 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 4466 | 0.050 |
Why?
|
| Spinal Fusion | 2 | 2016 | 1025 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2013 | 1455 | 0.040 |
Why?
|
| S Phase | 1 | 2019 | 435 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 42271 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2022 | 831 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17071 | 0.040 |
Why?
|
| Chromogranins | 1 | 2017 | 172 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 305 | 0.040 |
Why?
|
| Microscopy | 1 | 2021 | 853 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 487 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 69278 | 0.040 |
Why?
|
| Neoplasms | 2 | 2021 | 19538 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 213 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2017 | 67320 | 0.040 |
Why?
|
| Adolescent | 3 | 2020 | 84957 | 0.030 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2013 | 41 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2013 | 24351 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 56052 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 1042 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 49071 | 0.030 |
Why?
|
| Skull | 1 | 2017 | 796 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2013 | 392 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 1281 | 0.030 |
Why?
|
| Butadienes | 1 | 2011 | 128 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8895 | 0.030 |
Why?
|
| Child | 2 | 2016 | 71361 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2015 | 10108 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6835 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 883 | 0.030 |
Why?
|
| Oncogenes | 1 | 2017 | 1212 | 0.030 |
Why?
|
| Patient Readmission | 2 | 2015 | 2917 | 0.030 |
Why?
|
| Homeostasis | 1 | 2022 | 3297 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 2436 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 28848 | 0.030 |
Why?
|
| Spine | 1 | 2017 | 1059 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 2963 | 0.030 |
Why?
|
| Mice | 4 | 2022 | 80803 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2019 | 2676 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2013 | 1577 | 0.020 |
Why?
|
| Animals | 6 | 2022 | 170849 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2011 | 3964 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2011 | 496 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 3975 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2011 | 430 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13898 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1761 | 0.020 |
Why?
|
| Mitochondria | 1 | 2022 | 3602 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2011 | 349 | 0.020 |
Why?
|
| Inpatients | 1 | 2018 | 2050 | 0.020 |
Why?
|
| Mammals | 1 | 2011 | 688 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2011 | 1192 | 0.020 |
Why?
|
| Software | 1 | 2021 | 4314 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2017 | 6669 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1659 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 3471 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 963 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 958 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 786 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2586 | 0.020 |
Why?
|
| Troponin T | 1 | 2011 | 707 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 2101 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2013 | 1456 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 13606 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2011 | 1137 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 1680 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2017 | 2479 | 0.020 |
Why?
|
| Linear Models | 1 | 2015 | 6088 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3557 | 0.020 |
Why?
|
| Medicaid | 1 | 2017 | 2479 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5265 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11265 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 10648 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9661 | 0.010 |
Why?
|
| Research Design | 1 | 2018 | 5835 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17251 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 8070 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12734 | 0.010 |
Why?
|
| Medicare | 1 | 2017 | 5077 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3998 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7631 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13807 | 0.010 |
Why?
|
| United States | 2 | 2017 | 65579 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2011 | 3857 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 14656 | 0.010 |
Why?
|
| Incidence | 1 | 2016 | 20496 | 0.010 |
Why?
|
| Calcium | 1 | 2011 | 5696 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10990 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 17137 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 19328 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 8130 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 33918 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59331 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 41159 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18495 | 0.010 |
Why?
|
Concepts
(204)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_